National Academies Press: OpenBook

Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006)

Chapter: Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005

« Previous: References
Suggested Citation:"Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
×

A
Participants and Invited Experts Between December 1, 2004, and June 27, 2005

Participants

December 1, 2004


Alan Breier

Vice President, Medical, and Chief Medical Officer

Eli Lilly and Company


Catherine D.DeAngelis

Editor-in-Chief

Journal of the American Medical Association


Jeffrey M.Drazen

Editor-in-Chief

New England Journal of Medicine


Lawrence Hirsch

Executive Director, Medical Communications

Merck Research Laboratories


Richard Kingham

Partner

Covington & Burling


Ronald Krall

Senior Vice President, World Wide Development, GlaxoSmithKline Pharmaceuticals


Alexa McCray

Director, Lister Hill National Center for Biomedical Communications

National Library of Medicine


Lana Skirboll (via phone)

Associate Director of Science Policy

Office of the Director

National Institutes of Health


Harold C.Sox

Editor

Annals of Internal Medicine


Melvyn L.Sterling

Chair, Council on Scientific Affairs

American Medical Association


Robert Temple (via phone)

Director, Office of Medical Policy

Center for Drug Evaluation and Research

U.S. Food and Drug Administration


Elias Zerhouni (via phone)

Director

National Institutes of Health

Suggested Citation:"Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
×

Invited Experts

Between December 1, 2004, and June 27, 2005


Alan Breier

Vice President, Medical and Chief Medical Officer

Eli Lilly and Company


Catherine D.DeAngelis

Editor-in-Chief

Journal of the American Medical Association


Jeffrey M.Drazen

Editor-in-Chief

New England Journal of Medicine


Lawrence Hirsch

Executive Director, Medical Communications

Merck Research Laboratories


John Hoey

Editor

Canadian Medical Association Journal


Christine Laine

Executive Secretary

Annals of Internal Medicine


Justin McCarthy

General Counsel, Pfizer Global Research and Development

Pfizer, Inc.


Frank Rockhold

Senior Vice President and Director, Biomedical Data Sciences

GlaxoSmithKline Pharmaceuticals Research and Development


Alfred Sandrock

Vice President, Medical Research-Neurology

Biogen Idec


Ralph Smalling

Vice President, Global Research and Development Policy Analysis

Amgen


Harold Sox

Editor

Annals of Internal Medicine

Suggested Citation:"Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
×
Page 49
Suggested Citation:"Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
×
Page 50
Next: Appendix B Workshop Agenda, Speakers, Panelists, and Participants - June 27, 2005 »
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report Get This Book
×
Buy Paperback | $43.00 Buy Ebook | $34.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

To improve public confidence in clinical research, a number of public and private groups have called for a publicly accessible, comprehensive, and transparent registry of relevant information on clinical trials for drugs and biologics. The public and various entities within the medical community (health care providers, researchers, medical journal editors, pharmaceutical companies, health insurers, and regulators) have different expectations and perceived needs regarding a public clinical trial registry.

The IOM Committee on Clinical Trial Registries hosted a workshop on June 27, 2005, to obtain much-needed input from members of the public, public advocate groups, and the broader community of journal editors, pharmaceutical and biotech leaders, NIH, and the FDA. Participants discussed the data elements that have been at the core of debate and commented on issues of compliance and implementation of a national clinical trial registry.

Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report inlcudes discussions at the workshop centered on the following five concepts, and are described within this report: 1) Purpose, 2) Which Trials to Include, 3) Delayed Disclosure Mechanism, 4) Reporting Results of Completed Trials, and 5) Compliance.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!